Table of Contents

company-logo

DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.

DermTech Dividend Announcement

• DermTech does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on DermTech dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

DermTech Dividend History

DermTech Dividend Yield

DermTech current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing DermTech stock? Use our calculator to estimate your expected dividend yield:

DermTech Financial Ratios

P/E ratio-0.04
PEG ratio0.00
P/B ratio0.08
ROE-138.79%
Payout ratio0.00%
Current ratio3.53
Quick ratio3.46
Cash Ratio2.20

DermTech Dividend FAQ

Does DermTech stock pay dividends?
DermTech does not currently pay dividends to its shareholders.
Has DermTech ever paid a dividend?
No, DermTech has no a history of paying dividends to its shareholders. DermTech is not known for its dividend payments.
Why doesn't DermTech pay dividends?
There are several potential reasons why DermTech would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will DermTech ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While DermTech has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is DermTech a dividend aristocrat?
DermTech is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is DermTech a dividend king?
DermTech is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is DermTech a dividend stock?
No, DermTech is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy DermTech stocks?
To buy DermTech you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy DermTech stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.